Aehr Test Systems jumps as investors digest updated AI burn-in narrative ahead of conference presentation

Aehr Test Systems (AEHR) is up 21.4% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to renewed investor attention around AEHR’s AI-related test and burn-in opportunity heading into management’s William Blair conference presentation, alongside circulation of an updated June 2026 company slide deck that highlights manufacturing capacity and AI/data-center use cases. With the stock already primed by recent large AI-customer order headlines, incremental visibility or optimism into fiscal 2027 shipment ramps may be amplifying the reaction.

Details:

Aehr announced its CEO and CFO would present at the William Blair 46th Annual Growth Stock Conference on June 2, 2026, and meet with institutional investors throughout the day.

An updated June 2026 investor presentation circulated publicly, emphasizing AEHR’s Fremont manufacturing footprint and infrastructure capacity, and positioning wafer-level and package-level burn-in as critical for AI processors, data centers, and silicon photonics.

Earlier in the cycle, the company disclosed a record $41 million production order from a lead hyperscale AI customer and said second-half bookings exceeded $92 million, which likely set a bullish backdrop for follow-through buying on fresh conference-related visibility.

Speculation: traders may be extrapolating that large bookings convert into near-term shipments and recurring WaferPak/consumables demand, pushing expectations higher ahead of future earnings updates.

Sources:

Aehr Test Systems (press release/newsroom), Aehr Test Systems (company presentation), Investing.com

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$AEHR Insider Trading Activity

$AEHR insiders have traded $AEHR stock on the open market 50 times in the past 6 months. Of those trades, 0 have been purchases and 50 have been sales.

Here’s a breakdown of recent trading of $AEHR stock by insiders over the last 6 months:

GAYN ERICKSON (President and CEO) has made 0 purchases and 2 sales selling 152,824 shares for an estimated $10,786,791.
GEOFFREY GATES SCOTT (Director) has made 0 purchases and 5 sales selling 95,000 shares for an estimated $8,033,250.
RHEA J POSEDEL (Director) has made 0 purchases and 8 sales selling 100,504 shares for an estimated $7,619,263.
HOWARD T SLAYEN has made 0 purchases and 2 sales selling 31,819 shares for an estimated $2,839,153.
ALBERTO SALAMONE (EVP, PPBI BUSINESS) has made 0 purchases and 2 sales selling 30,000 shares for an estimated $2,761,950.
VERNON ROGERS (Exec VP of Sales & Mktg.) has made 0 purchases and 5 sales selling 29,805 shares for an estimated $2,475,620.
DONALD P. II RICHMOND (CTO) has made 0 purchases and 2 sales selling 32,762 shares for an estimated $2,326,659.
FARIBA DANESH (Director) has made 0 purchases and 3 sales selling 18,500 shares for an estimated $1,406,628.
ADIL ENGINEER (Chief Operating Officer) has made 0 purchases and 4 sales selling 16,813 shares for an estimated $1,139,350.
LAURA OLIPHANT (Director) has made 0 purchases and 8 sales selling 13,927 shares for an estimated $887,013.
ALISTAIR N SPORCK (VP Contactor Business Unit) has made 0 purchases and 5 sales selling 9,000 shares for an estimated $568,196.
DIDIER WIMMERS (Executive VP of R&D) has made 0 purchases and 2 sales selling 5,400 shares for an estimated $385,731.
CHRIS SIU (CFO) has made 0 purchases and 2 sales selling 2,070 shares for an estimated $221,608.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive AEHR Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$AEHR Hedge Fund Activity

We have seen 114 institutional investors add shares of $AEHR stock to their portfolio, and 80 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

PRICE T ROWE ASSOCIATES INC /MD/ added 1,314,967 shares (+3824.4%) to their portfolio in Q1 2026, for an estimated $48,758,976
GOLDMAN SACHS GROUP INC added 1,086,001 shares (+616.9%) to their portfolio in Q1 2026, for an estimated $40,268,917
WELLINGTON MANAGEMENT GROUP LLP removed 677,779 shares (-81.6%) from their portfolio in Q1 2026, for an estimated $25,132,045
HALTER FERGUSON FINANCIAL INC. removed 627,498 shares (-97.7%) from their portfolio in Q1 2026, for an estimated $23,267,625
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC removed 398,389 shares (-44.6%) from their portfolio in Q4 2025, for an estimated $8,043,473
FMR LLC removed 365,281 shares (-14.6%) from their portfolio in Q1 2026, for an estimated $13,544,619
INVESCO LTD. removed 338,351 shares (-92.3%) from their portfolio in Q4 2025, for an estimated $6,831,306

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$AEHR Analyst Ratings

Wall Street analysts have issued reports on $AEHR in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

William Blair issued a "Outperform" rating on 03/02/2026

To track analyst ratings and price targets for $AEHR, check out Quiver Quantitative's $AEHR forecast page.

$AEHR Price Targets

Multiple analysts have issued price targets for $AEHR recently. We have seen 2 analysts offer price targets for $AEHR in the last 6 months, with a median target of $25.0.

Here are some recent targets:

Christian Schwab from Craig-Hallum set a target price of $21.0 on 01/09/2026
An analyst from Lake Street set a target price of $29.0 on 12/17/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.